Protein C deficiency is a condition that raises the risk of abnormal blood clots because the body has too little of a natural anticoagulant protein, or the protein it has does not work properly. It can be inherited from birth or acquired later in life through conditions such as liver disease or certain medications. This guide explains what protein C does, how to read a low or high result on your lab report, what causes a deficiency, and why the timing of testing matters. You will also find a plain-language summary of recent research and a clear list of warning signs that call for prompt medical attention.
What is protein C and why does it matter?
Protein C is a small protein made by the liver that circulates in your blood in an inactive form. When your body needs to keep clotting under control, it converts protein C into its active form, called activated protein C (APC). This active protein then blocks two other clotting factors, factor Va and factor VIIIa, which slows down the clotting cascade. In simple terms, protein C works as a brake that keeps your blood clotting system from going too far.
This braking action matters because clotting is a balancing act. Your body needs to form clots to stop bleeding after an injury, but it also needs to prevent clots from forming inside intact blood vessels. Protein C is one of several natural anticoagulants, alongside protein S and antithrombin, that keep this balance in check. A doctor typically orders a protein C test after an unexplained or recurrent blood clot, or when a close relative has a known clotting disorder.
プロテインCの検査結果の読み方
検査報告書には通常、プロテインCが正常活性に対するパーセンテージで記載され、その横に検査機関の基準範囲が示されています。成人の一般的な基準範囲はおよそ70〜140%ですが、検査機関や測定方法によって異なります。インターネット上の数値と比較するのではなく、必ずご自身の報告書に記載されている基準範囲と照らし合わせてください。
検査機関によっては、プロテインCの「活性値」（タンパク質がどれだけ正常に機能しているかを測定）と「抗原量」（機能に関わらずタンパク質がどれだけ存在するかを測定）の2つの値を別々に報告する場合があります。両方を測定することで、次のセクションで説明する2種類の遺伝性欠乏症を区別するのに役立ちます。「L」の表示、下向きの矢印、または赤字でフラグが立てられた結果は、通常、基準範囲を下回っていることを示しています。
| プロテインC活性レベル | 一般的な分類 |
|---|---|
| 70%超 | 通常、正常基準範囲内 |
| 50〜70% | 軽度欠乏；定期的な経過観察が行われることが多い |
| 30〜50% | 中等度欠乏；通常は専門医による評価が行われる |
| 30%未満 | 重度欠乏；血液内科による密な経過観察が必要 |
これらの区分はあくまでも目安であり、固定された基準値ではありません。また、ご自身の検査機関の基準範囲が常に優先されます。1回の低値だけでは永続的な欠乏症の確定にはなりません。日常的なさまざまな状況によって一時的に値が低下することがあり、その詳細については次のセクションで説明します。
検査のタイミングと薬が結果に影響する理由
プロテインC検査には、多くの患者さんが見落としがちな実際的な注意点があります。不適切なタイミングで採血すると、結果が誤った値を示す可能性があります。急性血栓症の最中や直後に検査を行うと、血栓形成そのものによって凝固関連タンパク質が一時的に消費されるため、実際より低い値が出ることがあります。このため、医師は通常、血栓の治療後に患者さんの状態が安定してから少なくとも数週間後に検査を行うことを推奨しています。
抗凝固薬を使用している場合は、さらに状況が複雑になります。ワルファリンはプロテインCの産生を低下させます。これは、プロテインCが機能するためにビタミンKを必要とするためです。そのため、ワルファリン服用中に検査を行うと、プロテインCが本来正常な方でも、人工的に低い値が出ることがあります。直接経口抗凝固薬（DOAC）も一部の機能的アッセイに影響を与える場合があります。このため、遺伝性欠乏症の可能性を調べる医師は、医師の管理のもとで抗凝固療法を一時中断または完了させてから、診断用の採血を行うことが多いです。
Pregnancy is another situation that shifts results, since protein C levels often stay stable or rise slightly during pregnancy to help balance the naturally higher clotting tendency of that period. A result taken during pregnancy is therefore interpreted with that context in mind.
Protein C deficiency: inherited and acquired forms
Protein C deficiency falls into two broad categories depending on whether it is present from birth or develops later from another medical condition.
Hereditary protein C deficiency
Hereditary deficiency is caused by a mutation in the PROC gene, which carries the instructions for making protein C. According to MedlinePlus Genetics, a service of the National Library of Medicine, this condition is inherited in an autosomal dominant pattern, meaning a single altered gene copy is usually enough to cause a mild deficiency, while inheriting two altered copies causes a much more severe form. Mild hereditary protein C deficiency affects roughly 1 in 500 people in the general population, though most never develop a clot.
Geneticists split hereditary deficiency into two types. Type I involves a straightforward shortage of protein C, so both the activity and antigen levels are low together. Type II involves a normal amount of protein that does not function correctly, so the antigen level looks normal while the activity level is reduced. This is why doctors sometimes order both tests rather than activity alone.
Acquired protein C deficiency
An acquired deficiency develops because of another condition rather than a gene change, and it usually improves once the underlying cause is treated. Common triggers include:
- Severe liver disease, since the liver manufactures protein C.
- Vitamin K deficiency, because protein C production depends on vitamin K.
- Disseminated intravascular coagulation (DIC), a serious condition that rapidly uses up clotting proteins throughout the body.
- Warfarin therapy, particularly in the first days of treatment.
- Severe infection or sepsis, and the period immediately following major surgery.
Warfarin-induced skin necrosis: a critical safety issue
プロテインCの生物学的特性には、医学的緊急事態として認識されているため、特に説明が必要な重要な側面があります。ワルファリンはビタミンKの再利用を阻害し、時間の経過とともに複数の凝固因子を低下させますが、プロテインCは半減期が非常に短く、血栓形成を促進する凝固因子よりも早く低下します。ワルファリン治療開始後の1〜3日間、この特性により凝固活性が低下する前に一時的に上昇するという逆説的な状態が生じることがあり、これは「ワルファリン誘発性過凝固状態」と呼ばれることがあります。
プロテインC欠乏症がすでに診断されていない人では、この時期に皮膚の細小血管に小さな血栓が生じ、大腿部・臀部・乳房などに痛みを伴う赤または紫色の斑点が現れることがあります。放置すると組織壊死に進行する可能性があります。これを「ワルファリン誘発性皮膚壊死」といいます。クリーブランドクリニックによると、この合併症はまれであり、臨床医はヘパリンなどの速効性抗凝固薬をワルファリンと同時に開始し、ワルファリンが十分に効果を発揮するまで継続することでリスクを軽減します。この方法は「ブリッジング療法」と呼ばれています。
ご自身やご家族がワルファリンを開始して、治療開始から1週間以内に新たな痛みを伴う皮膚の変色に気づいた場合は、通常の経過観察の電話ではなく、速やかに医療機関を受診してください。
プロテインC異常に関連する疾患
欠乏症以外にも、血栓性素因の検査でプロテインCとともに頻繁に取り上げられる関連疾患がいくつかあります。
活性化プロテインC抵抗性
この状態では、プロテインCは正常なレベルで存在し、正常に活性化されますが、プロテインCが標的とする凝固因子がその抑制効果に抵抗します。最も一般的な原因は第V因子遺伝子の変異（第V因子ライデン変異）で、活性化プロテインCが第Va因子を効率よく不活化できないよう、その形状を変化させます。これは遺伝性の凝固リスク因子の中でも比較的よく見られるもので、特にヨーロッパ系の人々に多く認められます。
プロテインC高値
プロテインCの上昇は欠乏症よりもはるかにまれであり、それ単独では通常問題になりません。急性炎症時に体の代償反応の一環として現れることがあるほか、特定の薬剤との関連で見られることもあります。低値とは異なり、高値は特定の出血性疾患や血栓性疾患との関連は通常なく、治療を必要としないことがほとんどです。
受診のタイミング
Protein C deficiency itself is usually silent until a clot forms, so recognizing the symptoms of a clot is more urgent than watching the number on a lab report. Seek emergency care immediately for any of the following:
- Sudden swelling, pain, warmth, or redness in one leg or arm, which can signal a deep vein thrombosis.
- Sudden shortness of breath, sharp chest pain that worsens with breathing, or coughing up blood, which can signal a pulmonary embolism.
- New, painful, spreading skin discoloration during the first days of starting warfarin.
- Sudden weakness on one side of the body, trouble speaking, or vision changes, which can signal a stroke.
Contact your doctor promptly, though not necessarily as an emergency, if you have a family history of clotting disorders and are planning pregnancy, starting hormonal birth control, or scheduling major surgery, since these situations may call for testing or preventive measures ahead of time.
Managing a confirmed deficiency
Management is individualized and depends on the severity of the deficiency and whether you have already had a clot. Many people with a mild, asymptomatic deficiency need no daily treatment at all, only closer attention during high-risk periods such as surgery, pregnancy, or long periods of immobility. People who have already had a clot are more likely to need longer-term anticoagulant therapy, with the choice of medication and duration set by a hematologist.
Lifestyle measures support this medical care without replacing it. Staying active, avoiding long periods of sitting, not smoking, and maintaining a healthy weight can all help reduce overall clotting risk. If you take an anticoagulant, keep your vitamin K intake consistent from day to day rather than avoiding it altogether, since sudden swings in vitamin K intake can affect how well the medication works.
最新の科学的進歩
Research on protein C deficiency has continued to refine how doctors think about testing and treatment choices. A 2023 communication from the International Society on Thrombosis and Haemostasis (ISTH) reviewed the evidence on using direct oral anticoagulants, a newer and more convenient class of blood thinner, in people with severe inherited clotting disorders, including protein C deficiency. The available evidence, drawn mostly from smaller cohort studies rather than large randomized trials, suggested that direct oral anticoagulants work about as well as older medications like warfarin for most patients, though the group cautioned that data remain limited for the most severe cases. What this means for you: if you or a family member has protein C deficiency and your doctor recommends a direct oral anticoagulant instead of warfarin, that choice is supported by the current evidence for most situations, though your hematologist will still weigh your individual severity before deciding.
A 2023 review in the journal Hematology, published through the American Society of Hematology’s education program, examined common pitfalls in thrombophilia testing generally, and specifically described a rare form of protein C deficiency that can be missed by the most common laboratory method, because that particular method does not capture every way the protein can malfunction. This finding, based on expert case observations rather than a large trial, is an early, still-developing piece of evidence, but it reinforces why interpretation always belongs with a specialist who can choose the right test and account for its limitations, rather than relying on a single lab value in isolation.
Beyond specific findings, thrombophilia specialists have also emphasized in recent literature that protein C deficiency appears to raise the risk of clots in the veins, such as DVT and pulmonary embolism, much more clearly than it raises the risk of clots in the arteries, such as those behind a heart attack or stroke. This distinction is still being refined as larger population studies become available, but it already shapes how doctors counsel patients: a protein C result mainly informs vein-clot risk, and other risk factors are weighed separately for artery-related disease.
用語集
| 用語 | 定義 |
|---|---|
| Activated protein C (APC) | The active form of protein C that blocks clotting factors Va and VIIIa to slow the clotting cascade. |
| 抗凝固薬 | A substance, natural or medicinal, that slows or prevents blood clotting. |
| 深部静脈血栓症（DVT） | A blood clot that forms in a deep vein, most often in the leg. |
| 播種性血管内凝固症候群（DIC） | A serious condition in which widespread clotting throughout the body uses up clotting proteins, raising both clotting and bleeding risk. |
| Factor V Leiden | A common gene variant that makes clotting factor V resistant to activated protein C, raising clot risk. |
| PROC gene | The gene that carries the instructions for making protein C; mutations here cause hereditary deficiency. |
| 肺塞栓症（PE） | A blockage in a lung artery, usually caused by a clot that traveled from a deep vein. |
| 血栓性素因（血栓形成傾向） | A general term for any condition, inherited or acquired, that increases the tendency to form blood clots. |
| Warfarin-induced skin necrosis | A rare, serious complication in the first days of warfarin treatment where skin tissue dies due to small clots, more likely in undiagnosed protein C deficiency. |
よくある質問
Is protein C deficiency the same as protein S deficiency?
No, though the two are closely related and often tested together. Protein C is the primary anticoagulant enzyme, while protein S acts as its cofactor, helping activated protein C work more efficiently. A person can have either deficiency alone or both together, and each is linked independently to a higher risk of venous clots. Doctors investigating unexplained thrombosis commonly order both tests as part of the same thrombophilia panel.
Can protein C deficiency cause a miscarriage?
Protein C deficiency has been studied as one possible contributor to pregnancy complications, including recurrent miscarriage, likely related to small clots affecting the placenta. However, the relationship is not fully established for every case, and many pregnancies in people with a known deficiency proceed without complications, especially with monitoring. If you have a diagnosed deficiency and are pregnant or planning pregnancy, discuss a monitoring plan with a hematologist or maternal-fetal medicine specialist.
Does protein C deficiency ever go away?
A hereditary deficiency caused by a PROC gene mutation is lifelong, since it reflects your genetic makeup rather than a temporary state. An acquired deficiency caused by liver disease, vitamin K deficiency, or a medication effect can improve or resolve once the underlying cause is treated. This is one reason your doctor may recommend retesting after an acute illness or medication change, rather than accepting a single result as final.
What foods should I avoid with protein C deficiency?
There is no specific diet required for protein C deficiency itself. The main dietary consideration applies only if you are taking warfarin, since this medication depends on a stable vitamin K intake to work predictably. In that case, the goal is consistency, not avoidance: eating leafy greens and other vitamin K sources in a steady pattern rather than swinging between very low and very high intake. Ask your care team before making major diet changes if you are on any anticoagulant.
Is genetic testing necessary to diagnose protein C deficiency?
Genetic testing is not required to make the diagnosis, which is usually based on repeated low protein C activity and antigen levels on standard blood tests. Genetic testing for a PROC mutation can be useful in specific situations, such as confirming the cause in someone with a strong family history, clarifying results in a family member of a known carrier, or distinguishing a hereditary form from a temporary, acquired one. Your hematologist can advise whether it adds value in your specific case.
Can I exercise normally with protein C deficiency?
Yes, regular physical activity is generally encouraged rather than restricted, since staying active helps blood flow well and supports overall vascular health. The main precaution relates to prolonged immobility rather than exercise itself: long flights, extended bed rest, or sitting still for many hours are the situations that raise clotting risk, not moderate or vigorous activity. If you are planning an activity with a high injury risk while on an anticoagulant, discuss precautions with your doctor beforehand.
Protein C deficiency sits within a broader picture of how well your blood clots, and understanding one marker in isolation rarely tells the full story. Interpreting a coagulation result such as protein C alongside related markers like protein S levels, antithrombin III activityなど）、および D-dimer clot marker gives a clearer, more complete picture than any single number. AI DiagMe reads your uploaded lab report and explains each of these values in plain language, helping you understand what your results show, not diagnosing you or replacing your doctor.
AI DiagMeで血液検査の結果をわかりやすく確認
参考文献
- Protein C Deficiency — MedlinePlus Genetics, National Library of Medicine (NIH)
- Protein C Deficiency: What Is It, Causes, Symptoms and Treatment — Cleveland Clinic
- About Venous Thromboembolism (Blood Clots) — CDC
- Chiasakul and Bauer, The dos, don’ts, and nuances of thrombophilia testing, Hematology Am Soc Hematol Educ Program, 2023 (DOI)
- Kovac et al., The use of direct oral anticoagulants in the secondary prevention of venous thromboembolism in patients with severe thrombophilia: communication from the ISTH SSC Subcommittee, Journal of Thrombosis and Haemostasis, 2024 (DOI)
関連記事
- プロテインS検査の結果：数値の意味と重要性を理解する
- 凝固検査の解説：PT、PTT、INR、Dダイマー
- ビタミンK：検査結果を理解して正しく対処する
- 肺塞栓症：症状・検査・治療
- 血液検査の結果の見方：完全ガイド
